Fortress Biotech, Inc. (FBIO) vs Fractyl Health, Inc. (GUTS)
Fortress Biotech, Inc. and Fractyl Health, Inc. are both Biotechnology companies. Fortress Biotech, Inc. and Fractyl Health, Inc. are of similar size ($76.4M and $76.0M). Fractyl Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.7×. Fortress Biotech, Inc. grew revenue faster over the last twelve months: 15.5% against −22.5%. Fortress Biotech, Inc. has the higher net margin (151.0% vs 0.00%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 16 metrics below, Fortress Biotech, Inc. leads on 12 and Fractyl Health, Inc. on 4.
Valuation
Profitability
| Metric | FBIO | GUTS | Biotechnology median |
|---|---|---|---|
| Gross margin | 65.59% | 46.24% | 65.16% |
| Operating margin | (42.61%) | 0.00% | 0.00% |
| Net margin | 150.98% | 0.00% | 0.00% |
| Free cash flow margin | 183.80% | 0.00% | 0.00% |
| Return on equity | 84.91% | 1,063.04% | (57.72%) |
| Return on assets | 43.38% | (146.75%) | (49.22%) |
| Return on invested capital | (41.34%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack